Sagimet Biosciences (SGMT) Non Operating Income (2022 - 2026)

Sagimet Biosciences' Non Operating Income history runs 5 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Non Operating Income fell 37.06% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $5.2 million (down 38.07% YoY), while the FY2025 annual figure was $5.9 million, down 34.16% from the prior year.
• Non Operating Income was $1.1 million for Q1 2026 at Sagimet Biosciences, down from $1.2 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $2.5 million in Q2 2024 to a low of $136000.0 in Q2 2022.
• Historically, Non Operating Income has averaged $1.2 million across 5 years, with a median of $1.3 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Non Operating Income surged 1101.69% in 2024, then plunged 39.97% in 2025.
• A 5-year view of Non Operating Income shows it stood at $193000.0 in 2022, then soared by 581.35% to $1.3 million in 2023, then surged by 51.63% to $2.0 million in 2024, then sank by 39.97% to $1.2 million in 2025, then retreated by 11.19% to $1.1 million in 2026.
• The last three Non Operating Income figures came in at $1.1 million (Q1 2026), $1.2 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.